Not unexpectedly the news flow from our annual wacky dance has begun and the first round belongs to the toy makers. So, let’s not waste any time and get right too it-
Yesterday Bigfoot Biomedical announced they had acquired the Timesulin® insulin pen time cap. Per a company issued press release;
“Bigfoot Biomedical, Inc., a new kind of medical device company harnessing the power of machine learning to automatically and continuously optimize insulin delivery for people with insulin-requiring diabetes, today announced that it has acquired London-based biotech company Patients Pending, LTD, makers of the Timesulin® insulin pen . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.